Jeffrey S. Ginsberg

Jeffrey S. Ginsberg's AcademicInfluence.com Rankings

Jeffrey S. Ginsberg

Philosophy

#6273

World Rank

#9280

Historical Rank

Logic

#3453

World Rank

#4611

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Jeffrey S. Ginsberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeffrey S. Ginsberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (2000) (1517)
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. (1996) (1191)
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. (1999) (1125)
Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism (1998) (995)
Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. (1997) (773)
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. (2003) (741)
Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. (2000) (679)
Use of antithrombotic agents during pregnancy. (1992) (672)
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. (2009) (662)
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. (1998) (638)
Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. (2008) (583)
Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review (1999) (549)
Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (512)
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. (1990) (486)
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. (2000) (481)
The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism (1998) (441)
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial (2014) (425)
Determinants of health‐related quality of life during the 2 years following deep vein thrombosis (2008) (420)
Relationship between deep venous thrombosis and the postthrombotic syndrome. (2004) (414)
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. (2014) (384)
Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis (1995) (383)
Antiphospholipid antibodies and venous thromboembolism. (1995) (381)
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. (1996) (370)
Deep vein thrombosis and its prevention in critically ill adults. (2001) (340)
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. (2003) (325)
A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. (1994) (310)
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. (1998) (286)
Prevention and treatment of postphlebitic syndrome: results of a 3-part study. (2001) (276)
Management of venous thromboembolism. (1996) (272)
Optimal therapeutic level of heparin therapy in patients with venous thrombosis. (1992) (258)
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. (2005) (255)
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. (2000) (249)
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? (2001) (232)
Treatment of Deep-Vein Thrombosis (2004) (226)
The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. (2002) (223)
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread (1999) (222)
Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty (2002) (219)
Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. (1998) (214)
Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and d-dimer Testing (2001) (213)
Venous Thrombosis during Pregnancy: Leg and Trimester of Presentation (1992) (211)
Incidence of venographically proved deep vein thrombosis after knee arthroscopy. (1998) (204)
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. (1998) (200)
Risks to the Fetus of Anticoagulant Therapy During Pregnancy (1989) (197)
Heparin therapy during pregnancy. Risks to the fetus and mother. (1989) (190)
Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. (2002) (185)
Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis (2005) (185)
Comparison of Venography and Ultrasound for the Diagnosis of Asymptomatic Deep Vein Thrombosis in the Upper Body in Children (2002) (184)
Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. (2004) (183)
Risks to the Fetus of Radiologic Procedures Used in the Diagnosis of Maternal Venous Thromboembolic Disease (1989) (179)
Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. (2001) (175)
Does this patient have pulmonary embolism? (2003) (173)
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular- Weight Heparin for Acute Treatment of Venous Thromboembolism (2006) (166)
The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density (1996) (157)
Oral Anticoagulation Therapy in Pediatric Patients: a Prospective Study (1994) (155)
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double‐blind study (2003) (152)
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor (2004) (150)
Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. (2000) (145)
Anticoagulation of pregnant women with mechanical heart valves. (2003) (144)
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. (1991) (143)
Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial (2009) (143)
A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis (2003) (142)
Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis (1999) (141)
Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation (2011) (140)
Anatomic distribution of deep vein thrombosis in pregnancy (2010) (138)
A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process (1998) (135)
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. (1997) (132)
Guidance for the prevention and treatment of the post-thrombotic syndrome (2016) (132)
Paroxysmal Nocturnal Hemoglobinuria and the Risk of Venous Thrombosis: Review and Recommendations for Management of the Pregnant and Nonpregnant Patient (2000) (130)
A Red Blood Cell Agglutination d-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy (2007) (130)
How we manage venous thromboembolism during pregnancy. (2002) (129)
Does this patient have deep vein thrombosis? (1998) (128)
An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism (2006) (127)
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. (2015) (127)
Elevated cardiac troponin levels in patients with submassive pulmonary embolism. (2002) (126)
Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin (1998) (126)
Predicting Deep Venous Thrombosis in Pregnancy: Out in LEFt Field? (2009) (126)
Heparin Effect on Bone Density (1990) (125)
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. (2008) (123)
The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study (1991) (119)
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial. (1990) (119)
Application of a Novel and Rapid Whole Blood Assay for D-Dimer in Patients with Clinically Suspected Pulmonary Embolism (1995) (115)
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. (1996) (111)
Emery's elements of medical genetics (2015) (110)
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. (1992) (108)
Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism (2004) (107)
D‐dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis (2010) (106)
Safety of Withholding Heparin in Pregnant Women With a History of Venous Thromboembolism (2001) (105)
Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin (2003) (105)
Use of different d‐dimer levels to exclude venous thromboembolism depending on clinical pretest probability (2004) (104)
A latex D-dimer reliably excludes venous thromboembolism. (2001) (103)
Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. (1998) (101)
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded (2012) (101)
Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. (2006) (101)
Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study. (1999) (97)
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement (2007) (97)
A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ‘ART’ behind the clot (2006) (97)
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. (1996) (95)
Venous thrombosis in patients who have undergone major hip or knee surgery: detection with compression US and impedance plethysmography. (1991) (93)
Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. (1999) (93)
Low-molecular weight heparin in the treatment of patients with venous thromboembolism: the Columbus Investigators (1997) (92)
Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery. (1994) (91)
D-dimer in patients with clinically suspected pulmonary embolism. (1993) (89)
A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. (1997) (89)
Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. (1992) (88)
Management of venous thromboembolism during pregnancy (2003) (88)
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. (2005) (85)
Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study (2001) (84)
Initial Treatment of Venous Thromboembolism (2004) (83)
What determines the age at the menopause? (1991) (82)
Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. (1995) (81)
Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy (2002) (81)
Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery (1998) (81)
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study (2005) (79)
Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review (2006) (79)
Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests. (2000) (77)
A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism (2001) (76)
Low‐Molecular‐Weight Heparins: Are they all the Same? (2003) (75)
Comparison of the Villalta and Ginsberg clinical scales to diagnose the post‐thrombotic syndrome: correlation with patient‐reported disease burden and venous valvular reflux (2006) (75)
Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis. (2003) (74)
Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS) (2008) (73)
The APTT Response of Pregnant Plasma to Unfractionated Heparin (2002) (72)
Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin. (2001) (72)
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? (2013) (72)
Real‐world variability in dabigatran levels in patients with atrial fibrillation (2015) (72)
Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism (2008) (71)
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism (1995) (70)
Effectiveness of compression stockings to prevent the post-thrombotic syndrome (The SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial (2007) (68)
D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism (1992) (67)
Deep venous thrombosis and pulmonary embolism in pregnancy. (1992) (66)
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d-Dimer Testing Compared with Repeated Ultrasonography (2005) (66)
Subcutaneous Heparin Therapy during Pregnancy: a Need for Concern at the Time of Delivery (1991) (64)
Factors that predict thrombosis in relatives of patients with venous thromboembolism. (2014) (64)
Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials (2014) (63)
The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction (2008) (62)
Comparison of a Clinical Probability Estimate and Two Clinical Models in Patients with Suspected Pulmonary Embolism (2000) (62)
Use of antithrombotic agents during pregnancy. (1995) (60)
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. (2009) (59)
Selective d-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis (2013) (57)
Use of antithrombotic agents during pregnancy. (1993) (57)
Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents (2014) (57)
Tetracycline sclerosis in the management of malignant pericardial effusion. (1985) (56)
Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging (2013) (56)
Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. (1993) (55)
The Use of the D-Dimer Test in Combination with Non-Invasive Testing Versus Serial Non-Invasive Testing Alone for the Diagnosis of Deep-Vein Thrombosis (1992) (54)
Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. (1994) (53)
Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy. (2002) (53)
Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart (1992) (52)
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions (2014) (52)
Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post‐thrombotic syndrome (2015) (51)
Relation between D‐dimer level, venous valvular reflux and the development of post‐thrombotic syndrome after deep vein thrombosis (2010) (51)
Anticoagulants during pregnancy. (1989) (50)
Graduated compression stockings to treat acute leg pain associated with proximal DVT (2014) (49)
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. (2018) (49)
Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments] (1993) (48)
Thrombosis in antithrombin‐III‐deficient persons. Report of a large kindred and literature review (1993) (48)
Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia. (1997) (48)
The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group. (1998) (46)
Effect of warfarin on activated partial thromboplastin time in patients receiving heparin. (1998) (46)
The role of D‐dimer in the diagnosis of venous thromboembolism (1997) (45)
The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature. (2000) (44)
Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis (2018) (44)
Venous thromboembolism in older adults: A community-based study. (2014) (43)
Dose-Response Study of Recombinant Factor VIIa / Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c 2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement (2001) (41)
Differences in clinical presentation of deep vein thrombosis in men and women (2008) (41)
Pre-operative Plasma Levels of Thrombin-Antithrombin III Complexes Correlate with the Development of Venous Thrombosis after Major Hip or Knee Surgery (1995) (41)
5 Anticoagulants in pregnancy: fetal effects (1997) (39)
Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis. (2002) (39)
Betrixaban (PRT054021): pharmacology, dose selection and clinical studies. (2014) (38)
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. (2005) (35)
Diagnostic strategies for the management of patients with clinically suspected deep‐vein thrombosis (1997) (35)
Measurement of Markers of Activated Coagulation in Antithrombin III Deficient Subjects (1992) (34)
Clinical practice. Treatment of deep-vein thrombosis. (2004) (34)
A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal (2015) (33)
Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials (2005) (33)
Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism (2001) (30)
Thrombosis in pregnancy (1997) (30)
Free Protein S Deficiency May Be Found in Patients with Antiphospholipid Antibodies who Do not Have Systemic Lupus Erythematosus (1996) (30)
Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography. (1989) (28)
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. (2012) (28)
Role of phenotypic and genetic testing in managing clopidogrel therapy. (2014) (28)
Use of anticoagulants during pregnancy. (1989) (28)
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study. (2016) (28)
Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients (2004) (28)
The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus (1999) (27)
3 Laboratory diagnosis of venous thromboembolism (1998) (27)
Anticoagulants in pregnancy: fetal effects. (1997) (27)
Pregnancy and prosthetic heart valves (1994) (27)
Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study (2019) (27)
3 Laboratory diagnosis of venous thromboembolism (1998) (27)
Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial (2015) (26)
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis (2005) (25)
Intermittent compression units for the postphlebitic syndrome. A pilot study. (1989) (25)
Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study (2016) (25)
Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials (2015) (25)
Use of antithrombotic agents during pregnancy. (1998) (25)
Thromboembolism and Pregnancy (1999) (25)
Evaluation of a Soluble Fibrin Assay in Patients with Suspected Deep Vein Thrombosis (1995) (23)
Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer. (2018) (23)
Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). (2011) (23)
Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. (2005) (23)
The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study. (1993) (22)
The sensitivity and specificity of a red blood cell agglutination D-dimer assay for venous thromboembolism when performed on venous blood. (2002) (22)
Impact of research investment on scientific productivity of junior researchers (2016) (22)
Inherited thrombophilia and pregnancy associated venous thromboembolism. (2008) (22)
Effects on Thrombin Generation of Single Injections of Hirulog™ in Patients with Calf Vein Thrombosis (1994) (22)
Helical Computed Tomography and the Diagnosis of Pulmonary Embolism (2000) (21)
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions. (2006) (21)
Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis (2019) (21)
The Clinical Utility of a Rapid Bedside D-dimer Assay for Screening of Deep Vein Thrombosis following Orthopaedic Surgery (1997) (21)
Laboratory diagnosis of venous thromboembolism. (1998) (20)
Management of iliofemoral thrombosis in a pregnant patient with heparin resistance. (1997) (20)
Low-dose warfarin in rehabilitating stroke survivors. (2002) (19)
Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review (2020) (19)
Reading between the (Guidelines). Management of submassive pulmonary embolism in the first trimester of pregnancy. (2008) (18)
"ProC Global": A functional screening test that predicts recurrent venous thromboembolism (2005) (17)
The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy (2011) (17)
Pregnancy and deep vein thrombosis. (2001) (16)
Evaluation of the combination of a bedside D-dimer assay and enzyme-linked immunosorbent soluble fibrin assay in patients with suspected venous thromboembolism. (1997) (16)
New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism (2005) (16)
Evaluation of a Soluble Fibrin Assay in Patients with Suspected Pulmonary Embolism (1996) (16)
Update in the diagnosis of deep-vein thrombosis and pulmonary embolism (2006) (16)
The development and validation of an instrument to measure the quality of health research reports in the lay media (2017) (15)
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment. (2016) (15)
Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study (2018) (14)
Once versus twice daily aspirin after coronary bypass surgery: a randomized trial (2017) (14)
Anticoagulant therapy with ancrod. (1993) (14)
The diagnostic evaluation of deep vein thrombosis. (2004) (14)
Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial. (2012) (13)
Strategies for the diagnosis of deep vein thrombosis and pulmonary embolism. (2000) (13)
A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study. (2007) (13)
Evidence for the Needs of Out-of-Hospital Thrombosis ProphylaxisThe Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty: A Cohort Study of 1,984 Patients (1998) (12)
Diagnostic problems with venous thromboembolic disease in pregnancy. (1995) (12)
Intra-arterial low-dose streptokinase infusion for superior mesenteric artery embolus. (1990) (11)
Timing the First Postoperative Dose of Anticoagulants: Lessons Learned From Clinical Trials. (2015) (11)
Anticoagulation for venous thromboembolism (2007) (11)
Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis. (2000) (11)
Heparin and Graduated Compression Stockings in Patients: Undergoing Fractured Hip Surgery (1991) (11)
Arguments against Monitoring Levels of Anti-Factor Xa in Conjunction with Low-Molecular-Weight Heparin Therapy (2002) (11)
Diagnosis of venous thromboembolism in pregnancy: a study in extrapolation or a science in evolution? (2009) (10)
A Multicenter Randomized Placebo Controlled Trial of Compression Stockings to Prevent the Post-Thrombotic Syndrome After Proximal Deep Venous Thrombosis: The S.O.X. Trial (2012) (10)
Routine Stocking Therapy after Deep Venous Thrombosis: A Clinical Dilemma (2004) (10)
New anticoagulants for venous thromboembolic disease (2005) (10)
Compression stockings to prevent post-thrombotic syndrome – Authors' reply (2014) (9)
New antithrombotics. (1995) (9)
Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides (2013) (9)
Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism. (2000) (8)
Venous thrombosis of the upper extremities (2001) (8)
Wells PS, Hirsh J, Anderson DR, et al: Accuracy of clinical assessment of deep-vein thrombosis (1995) (8)
The cost and benefit of prophylaxis against deep-vein thrombosis in elective hip replacement (1997) (8)
Low molecular weight heparin and asa therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL) (1997) (7)
In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets (2018) (7)
Comparison of Performance of Two Clinical Scales To Diagnose the Post-Thrombotic Syndrome: Correlation with Patient-Reported Disease Burden and Valvular Reflux. (2005) (6)
Evidence-based hematology (2008) (6)
Real‐world variability in dabigatran levels in patients with atrial fibrillation: reply (2015) (6)
Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. (2006) (6)
Pseudothrombosis in pregnancy. (1988) (5)
Highlights of the Year in JACC 2005. (2006) (5)
DIAGNOSIS OF DEEP-VEIN THROMBOSIS (1989) (5)
DVT and pulmonary embolism: choosing the right diagnostic tests for patients at risk. (1995) (5)
Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information (2016) (5)
Evaluation of a VENOus-Return Assist Device (Venowave™) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial. (2006) (5)
Women's Vascular Health (2006) (5)
Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery (2018) (5)
Predictors of the Development of Post-Thrombotic Syndrome after Acute Symptomatic Deep Vein Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study). (2005) (5)
Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients (1999) (4)
Advances in the Diagnosis of Venous Thromboembolism A Multimodal Approach (2001) (4)
Uses of heparin. Ancrod for heparin induced thrombocytopenia. (1993) (4)
81 – Peripheral Venous Disease (2012) (4)
Heparin prophylaxis during pregnancy. (1990) (4)
Economic Burden and Cost Determinants of Deep Venous Thrombosis During the Two Years Following Diagnosis: a Prospective Evaluation (2010) (3)
The diagnostic evaluation of pulmonary embolism. (2005) (3)
Rebuttal to Partsch et al. “Pain relief by compression in acute DVT. A critique of Kahn et al.“ Thromb Haemost 2015; 113: 906. (2015) (3)
Management of Venous Thromboembolism in Pregnancy (2009) (3)
The Rational Clinical Examination Does This Patient Have Deep Vein Thrombosis (2001) (3)
Inflammation Markers and The Risk Of Post Thrombotic Syndrome: Results From The Bio-Sox Study (2013) (3)
Wormy wood? (1997) (3)
Uterine vein thrombosis: an unusual variant of pelvic vein thrombophlebitis. (1997) (3)
Management of pregnant women with prosthetic heart valves. (1998) (2)
The development and introduction of biosimilar anticoagulants – focus on enoxaparin (2012) (2)
Optimum Use of Anticoagulants in Pregnancy (1988) (2)
Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study (2003) (2)
Anticoagulation in pregnancy. (1999) (2)
Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. (2008) (2)
Use of antithrombotic agents pregnancy (1992) (2)
Bleeding after initiation of anticoagulant therapy for deep vein thrombosis. (1999) (2)
Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada (2018) (2)
Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study (2021) (2)
Bleeding in Patients with Atrial Fibrillation Treated with Non Vitamin K Antagonist Oral Anticoagulants: A Population-Based Study (2014) (2)
Incidence, timing of onset and severity of post-thrombotic syndrome after acute symptomatic deep vein thrombosis: Two-year results from a Canadian multicenter prospective cohort study (The VETO study) (2005) (2)
Bleeding in Patients with Atrial Fibrillation Treated with Different Doses of Direct Oral Anticoagulants and Vitamin K Antagonists: A Population-Based Study (2016) (2)
A randomized comparison of dalteparin versus unfractionated heparin during percutaneous coronary interventions (2003) (2)
Predictors Of The Post-Thrombotic Syndrome In a Large Cohort Of Patients With Proximal DVT: Secondary Analysis Of The Sox Trial (2013) (1)
EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT) (2007) (1)
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke (2020) (1)
How I treat How we manage venous thromboembolism during pregnancy (2002) (1)
Traitement antithrombotique pendant la grossesse (2000) (1)
Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial (2005) (1)
Determinants of Health-Related Quality of Life after Deep Venous Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study). (2005) (1)
Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable? (2021) (1)
Comparison ofximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement (2003) (1)
Mortality benefit in the COMPASS trial: is it related to superior statistical power or better efficacy and safety? (2020) (1)
Is There a Relationship Between the Intensity of Heparin Treatment and Recurrent Thomboembolism? (1997) (1)
Randomized trial to examine the effect of ASA dose or ASA dosing frequency on ASA resistance after coronary artery bypass graft surgery (2013) (1)
Thrombosis in Antithrombin-III-deficient Persons (2020) (1)
The national physicians cooperative (NPC) tissue study: ovarian tissue from pediatric patients removed for cryopreservation contains follicles regardless of treatment history (2014) (1)
Ximelagatran for prevention of venous thromboembolism in knee replacement (2004) (1)
The Effectiveness Of 30-40 Mm Hg Compression Stockings To Treat Acute Leg Pain Associated With Proximal Deep Vein Thrombosis: Results From The Sox Randomized Controlled Trial (2013) (1)
Clinical assessment and o-dimer testing in deep venous thrombosis. Authors' reply (2002) (0)
Diagnosis of deep vein th SUMMARY (2007) (0)
O8 Predicting DVT in pregnancy: out in “left” field? (2009) (0)
Effect of patient's sex on risk of recurrent venous thromboembolism : a meta-analysis. Commentary (2007) (0)
D-Dimerin PatientsWithClinically SuspectedPulmonary Embolism* (2017) (0)
Ce patient a-t-il une embolie pulmonaire ? (2004) (0)
D-dimer in patients with clinically suspected pulmonary embolism. 1993. (2009) (0)
Prediction Rules Must Be Developed According to Methodological Guidelines (2010) (0)
Venous Return Assist Devices for Intermittent Claudication: A Randomized Controlled Trial Utilizing a Sham Comparator (2019) (0)
Hodgkin's Disease 1985. (1985) (0)
Role of Gender in the Clinical Presentation of a First Deep Venous Thrombosis (DVT) in Outpatients. (2006) (0)
Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial (2003) (0)
Thromboembolism and pregnancy. (2001) (0)
Thrombosis research and the future (2003) (0)
THROMBOSIS IN ANTITHROMBIN-III DEFICIENCY. REPLY (1992) (0)
Measures of ovarian reserve in female cancer patients compared to naturally aging women (2008) (0)
A Randomized, Controlled Trial of Varying D-Dimer Cutpoints According to Clinical Pretest Probability Compared with a Uniform D-Dimer Cutpoint for Diagnosis of Deep Vein Thrombosis (2010) (0)
No magic formula: age is the most important factor in predicting return to baseline levels of ovarian reserve after cancer therapy (2018) (0)
THROMBOSIS AND HEMOSTASIS Factors that predict thrombosis in relatives of patients with venous thromboembolism (2014) (0)
Low-Molecular-Weight Heparin Use in Pregnancy (2002) (0)
Abstract (2003) (0)
Acute Ovarian Failure and Premature Ovarian Insufficiency in Childhood Cancer Survivors Who Received Radiotherapy: A PENTEC Report (2022) (0)
Compression ultrasound was not useful in symptom-free venous thrombosis (1994) (0)
Thromboses veineuses profondes : Héparine de bas poids moléculaire à domicile versus héparine non fractionnée à l'hôpital (1996) (0)
Hormonal Therapy in Women (2006) (0)
504 Subtle Differences in Commercial Heparins Can Have Serious Consequences for Cardiopulmonary Bypass Patients: a randomized controlled trial (2012) (0)
Review: Low-molecular weight heparin reduces the risk for developing deep-vein thrombosis and pulmonary embolism in patients having orthopedic surgery (1992) (0)
Absence of thrombin generation during therapy with a highly purified solvent/detergent treated factor IX concentrate (1993) (0)
Author Index / Subject Index, Vol. 25, 1995 (1995) (0)
Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0. (2005) (0)
Pregnancy increases the risk of venous thromboembolism (VTE) but the true incidence is unknown. The risk of VTE continues in the post-partum period and is probably higher than during pregnancy. (2004) (0)
Surgical Myocardial Revascularization in Patients with Acute Myocardial Infarction and Cardiogenic Shock: Data from the GERMIN-SURG Registry (2022) (0)
A 52-year-old-woman with no history of venous thromboembolism presents with a four-day history of discomfort in her left calf. Proximal deep-vein thrombosis is diag- nosed by compression ultrasonography. How should her case be managed? (2004) (0)
Low-molecular weight heparin in the treatment of patients with venous (2014) (0)
14 A red blood cell agglutination D-dimer test for the diagnosis of DVT in pregnancy: a prospective cohort study (2007) (0)
IMPEDANCE PLETHYSMOGRAPHY FOR SUSPECTED DEEP-VEIN THROMBOSIS. AUTHORS' REPLY (1995) (0)
Relationship between menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors (2018) (0)
d-Dimer Testing in Pregnancy: Clinically Useful, but at What Cost? (2008) (0)
Deep vein thrombosis and duplex ultrasound. (1990) (0)
CLINICAL MODEL FOR MANAGEMENT OF PULMONARY EMBOLISM. AUTHORS' REPLY (1999) (0)
MONITORING HEPARIN THERAPY. AUTHORS' REPLY (1994) (0)
C.W. Colwell Jr., S.D. Berkowitz, J.R. Lieberman, P.C. Comp, J.S, Ginsberg, G. Paiement, J. McElhattan, A. W. Roth, and C. W. Francis reply [10] (2006) (0)
Laboratory monitoring of oral anticoagulant therapy. (1989) (0)
Chapter 61. Venous Thromboembolic Disease (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jeffrey S. Ginsberg?

Jeffrey S. Ginsberg is affiliated with the following schools:

Jeffrey S. Ginsberg's Academic­Influence.com Rankings

Why Is Jeffrey S. Ginsberg Influential?

Jeffrey S. Ginsberg's Published Works

Published Works

What Schools Are Affiliated With Jeffrey S. Ginsberg?

Jeffrey S. Ginsberg's AcademicInfluence.com Rankings